Fundraising Fox

Omthera Pharmaceuticals

Princeton, US · Founded 2008 · 2 known investors

Biotech

Founders & leadership

GW
Gerald WislerNamed on SEC filing
GS
Graziano SeghezziNamed on SEC filing
CS
Christian SchadeNamed on SEC filing
DM
David MottNamed on SEC filing
GH
George HornerNamed on SEC filing

Investors · 2

Sofinnova PartnersParis · $540K – $27M
New Enterprise AssociatesreportedTimonium

Reported raises · per SEC filings

Form D private placements

$39M disclosed across 1 round · 2011

▶$39MraisedJan 2012 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gerald WislerExecutive Officer, Director
  • Graziano SeghezziDirector
  • Christian SchadeExecutive Officer
  • David MottDirector
  • George HornerDirector
Offering amount
$49M
Amount sold
$39M
First sale
Feb 2011
Incorporated
Corporation, Delaware, 2008
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Omthera Pharmaceuticals files for a $75 million IPO | Nasdaqnasdaq.com · Mar 2013Omthera rounds up $34M in Series B, adds David Mott to board | Fierce Biotechfiercebiotech.com · Mar 2011Omthera Raises $33M - FinSMEsfinsmes.com · Mar 2011Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding Led by New Enterprise Associates | Fierce Biotechfiercebiotech.com · Mar 2011Omthera Pharma Raises $6.5 Millionventurecapitaljournal.com · Mar 2010

Frequently asked questions

Who are Omthera Pharmaceuticals's investors?
Omthera Pharmaceuticals's investors include Sofinnova Partners, New Enterprise Associates.
How much funding has Omthera Pharmaceuticals raised?
Omthera Pharmaceuticals has disclosed $39M raised across 1 round.
Where is Omthera Pharmaceuticals headquartered?
Omthera Pharmaceuticals is headquartered in Princeton, US.